A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study is to directly compare repeat doses of sublingual and buccal
routes of 400 mcg misoprostol following mifepristone for second trimester abortion in order
to determine if sublingual route confers an advantage with respect to efficacy and median
time to complete abortion.
Phase:
Phase 4
Details
Lead Sponsor:
Gynuity Health Projects
Collaborators:
Clinic No. 2 of Tashkent Medical Academy Kathmandu Medical College and Teaching Hospital La Rabta Maternity Hospital Republican Institute of RH, Perinatology, and Ob/Gyn